UPDATE : Thursday, January 23, 2020
Samsung BioLogics files administrative suit to refute accounting fraud ruling
Samsung BioLogics said it filed an administrative suit on Nov. 14 to nullif...
by Nam Doo-hyun  |  2018-11-28 15:30
Pharmaceuticals, biotechs rise with KOSPI rebound
Shares of pharmaceutical and biotech companies moved up briskly on Monday, ...
by Nam Doo-hyun  |  2018-11-27 11:53
Celltrion’s Remsima tops global sale of ₩1 trillion
Celltrion Healthcare said Thursday that Remsima, a biosimilar of Remicade t...
by Lee Han-soo  |  2018-11-23 14:54
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun  |  2018-11-22 11:15
Celltrion CEO involved in alleged ‘gapjil’ scandal
Celltrion Chairman Seo Jung-jin has reportedly pulled a power trip – ...
by Lee Han-soo  |  2018-11-21 16:02
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun  |  2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar
Temixys, a generic developed by Celltrion to treat the human immunodeficien...
by Lee Han-soo  |  2018-11-21 12:57
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon  |  2018-11-20 15:00
Celltrion Healthcare presents research results on using biosimilars in Europe
Celltrion Healthcare said Monday that it has presented the financial saving...
by Lee Han-soo  |  2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US
Bridge Biotherapeutic announced on Monday that the company has filed an inv...
by Lee Han-soo  |  2018-11-19 11:58
Tego Science sales plunge in Q3
Tego Science said Thursday that its sales plunged to 2.1 billion won ($1.8 ...
by Lee Han-soo  |  2018-11-16 14:54
NIBEC wins patent for novel peptide in US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo  |  2018-11-16 14:40
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun  |  2018-11-16 11:30
Medipost mark profit losses in Q3
Medipost said Thursday that it recorded an operating loss of 780 million wo...
by Lee Han-soo  |  2018-11-15 15:18
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
The stock trading suspension of Samsung BioLogics due to the alleged accoun...
by So Jae-hyeon  |  2018-11-15 14:56
Celltrion Healthcare posts ₩212.7 billion in Q3 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Thursday that it reco...
by Lee Han-soo  |  2018-11-15 12:43
Regulators suspend trading of Samsung BioLogics on accounting fraud charges
The Korean Exchange suspended the share trading of Samsung BioLogics on Wed...
by Lee Han-soo  |  2018-11-14 18:28
Alteogen promote antibody-drug conjugate cancer treatment in US
Alteogen said Wednesday that it promoted ALT-P7, an antibody-drug conjugate...
by Lee Han-soo  |  2018-11-14 16:59
GCAM opens new plasma collection centers in US
GCAM, GC’s sister company, said Friday that it has added two additional pla...
by Lee Han-soo  |  2018-11-09 17:58
GC launches Biocon’s antidiabetic biosimilar
GC said Thursday that it has launched Biocon’s Glargia (insulin glargine), ...
by Lee Han-soo  |  2018-11-08 15:46
Back to Top